loadpatents
name:-0.10486507415771
name:-0.04035496711731
name:-0.0035359859466553
Vandenbark; Arthur A. Patent Filings

Vandenbark; Arthur A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vandenbark; Arthur A..The latest application filed is for "recombinant polypeptides comprising modified mhc class ii dra1 domains and methods of use".

Company Profile
2.28.35
  • Vandenbark; Arthur A. - Portland OR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
RECOMBINANT POLYPEPTIDES COMPRISING MODIFIED MHC CLASS II DRa1 DOMAINS AND METHODS OF USE
App 20210380660 - Meza-Romero; Roberto ;   et al.
2021-12-09
Recombinant CD74 polypeptides
Grant 10,689,446 - Meza-Romero , et al.
2020-06-23
Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor
Grant 10,525,101 - Vandenbark , et al. J
2020-01-07
Recombinant polypeptides comprising MHC class II .alpha.1 domains
Grant 10,316,075 - Vandenbark , et al.
2019-06-11
Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells
Grant 9,926,360 - Burrows , et al. March 27, 2
2018-03-27
Recombinant Cd74 Polypeptides
App 20170369577 - Meza-Romero; Roberto ;   et al.
2017-12-28
Recombinant T Cell Receptor Ligand Compositions And Methods For Treatment Of Prostate Cancer
App 20170196957 - Vandenbark; Arthur A. ;   et al.
2017-07-13
Compounds That Bind Macrophage Migration Inhibitory Factor
App 20170114117 - Vandenbark; Arthur A. ;   et al.
2017-04-27
Compositions and methods using recombinant MHC molecules for the treatment of stroke
Grant 9,492,536 - Offner , et al. November 15, 2
2016-11-15
Recombinant T-cell Receptor Ligand For The Treatment Of Cognitive And Neuropsychiatric Impairment Induced By Substance Addiction
App 20160271236 - Loftis; Jennifer ;   et al.
2016-09-22
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
Grant 9,359,425 - Vandenbark , et al. June 7, 2
2016-06-07
Monomeric Recombinant Mhc Molecules Useful For Manipulation Of Antigen-specific T-cells
App 20160102132 - Burrows; Gregory G. ;   et al.
2016-04-14
Treatment of retinal disorders with recombinant T cell receptor ligand (RTL)
Grant 9,260,506 - Adamus , et al. February 16, 2
2016-02-16
Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells
Grant 9,243,051 - Burrows , et al. January 26, 2
2016-01-26
Compositions And Methods Using Recombinant Mhc Molecules For The Treatment Of Stroke
App 20150343055 - Offner; Halina ;   et al.
2015-12-03
Compositions and methods using recombinant MHC molecules for the treatment of stroke
Grant 9,050,279 - Offner , et al. June 9, 2
2015-06-09
RECOMBINANT POLYPEPTIDES COMPRISING MHC CLASS II a1 DOMAINS
App 20150098956 - Vandenbark; Arthur A. ;   et al.
2015-04-09
TREATMENT OF ISCHEMIC STROKE WITH DRa1-MOG-35-55
App 20150099706 - Offner-Vandenbark; Halina ;   et al.
2015-04-09
Partial Mhc Constructs And Methods Of Use
App 20150044245 - Vandenbark; Arthur A. ;   et al.
2015-02-12
Recombinant T-cell Receptor Ligand For The Treatment Of Cognitive And Neuropsychiatric Impairment Induced By Substance Addiction
App 20150037363 - Vandenbark; Arthur A. ;   et al.
2015-02-05
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
Grant 8,895,018 - Vandenbark , et al. November 25, 2
2014-11-25
Antibodies Which Bind Soluble T-cell Receptor Ligands
App 20140170168 - Reiter; Yoram ;   et al.
2014-06-19
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
Grant 8,685,404 - Loftis , et al. April 1, 2
2014-04-01
Compositions And Methods Using Recombinant Mhc Molecules For The Treatment Of Stroke
App 20140056936 - Offner; Halina ;   et al.
2014-02-27
Recombinant T Cell Ligands And Antibodies That Bind B Cells For The Treatment Of Autoimmune Diseases
App 20130309229 - Yang; Jianhua ;   et al.
2013-11-21
Recombinant T-cell Receptor Ligand For The Treatment Of Cognitive And Neuropsychiatric Impairment Induced By Substance Addiction
App 20130273087 - Vandenbark; Arthur A. ;   et al.
2013-10-17
Monomeric Recombinant Mhc Molecules Useful For Manipulation Of Antigen-specific T-cells
App 20130190221 - Burrows; Gregory G. ;   et al.
2013-07-25
Compositions and methods using recombinant MHC molecules for the treatment of stroke
Grant 8,491,913 - Offner , et al. July 23, 2
2013-07-23
Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells
Grant 8,377,447 - Burrows , et al. February 19, 2
2013-02-19
Treatment Of Retinal Disorders With Recombinant T Cell Receptor Ligand (rtl)
App 20120276127 - Adamus; Grazyna ;   et al.
2012-11-01
Recombinant T-cell Receptor Ligand For The Treatment Of Cognitive And Neuropsychiatric Impairment Induced By Substance Addiction
App 20120195921 - Loftis; Jennifer ;   et al.
2012-08-02
Methods for detecting and treating autoimmune disorders
Grant 8,053,197 - Vandenbark , et al. November 8, 2
2011-11-08
Recombinant Mhc Molecules Useful For Manipulation Of Antigen-specific T-cells
App 20110262479 - Burrows; Gregory G. ;   et al.
2011-10-27
Compositions and methods using recombinant MHC molecules for the treatment of stroke
App 20110217308 - Offner; Halina ;   et al.
2011-09-08
T Cell Hybridomas And Related Compositions And Methods For Assaying And Modulating T Cell Receptor-Mediated Immune Responses
App 20100279401 - Burrows; Gregory G. ;   et al.
2010-11-04
Method for direct electrical detection of molecules and molecule-molecule interactions
Grant 7,732,140 - Vandenbark , et al. June 8, 2
2010-06-08
Methods for Detecting and Treating Autoimmune Disorders
App 20090010885 - Vandenbark; Arthur A. ;   et al.
2009-01-08
Methods of selecting T cell receptor V peptides for therapeutic use
Grant 7,462,486 - Vandenbark December 9, 2
2008-12-09
Recombinant MHC Molecules Useful For Manipulation Of Antigen-Specific T-Cells
App 20080267987 - BURROWS; Gregory G. ;   et al.
2008-10-30
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
App 20080064859 - Vandenbark; Arthur A. ;   et al.
2008-03-13
Method For Direct Electrical Detection Of Molecules And Molecule-molecule Interactions
App 20080036471 - Vandenbark; Arthur A. ;   et al.
2008-02-14
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
Grant 7,265,218 - Burrows , et al. September 4, 2
2007-09-04
Device for direct electrical detection of molecules and molecule-molecule interactions
Grant 7,214,528 - Vandenbark , et al. May 8, 2
2007-05-08
Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells
App 20050142142 - Burrows, Gregory G. ;   et al.
2005-06-30
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
App 20050074853 - Burrows, Gregory G. ;   et al.
2005-04-07
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
Grant 6,815,171 - Burrows , et al. November 9, 2
2004-11-09
Methods of selecting T cell receptor V peptides for therapeutic use
App 20030190665 - Vandenbark, Arthur A.
2003-10-09
T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
Grant 6,566,082 - Weinberg , et al. May 20, 2
2003-05-20
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
App 20030007978 - Burrows, Gregory G. ;   et al.
2003-01-09
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
App 20020176864 - Burrows, Gregory G. ;   et al.
2002-11-28
Methods of identifying and monitoring disease-associated T cells
App 20020107388 - Vandenbark, Arthur A.
2002-08-08
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
Grant 6,270,772 - Burrows , et al. August 7, 2
2001-08-07
Treatment of CD4 T-cell mediated conditions
Grant 5,759,546 - Weinberg , et al. June 2, 1
1998-06-02
T cell receptor peptides as therapeutics for immune-related disease
Grant 5,614,192 - Vandenbark March 25, 1
1997-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed